Program overview
Context
Indication: Colorectal Cancer
Mechanism: Unknown
Modality: Unknown
Sponsor: Eli Lilly and Company
Registry Stop Signal
Pemetrexed
Pemetrexed is flagged as registry stop signal because public records show a registry stop signal, public results not found after completion, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 5/5
Timeline: 1/5
Recruitment burden: 2/5
Results availability: 3/5
Program risk: 5/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT00079872 | https://clinicaltrials.gov/study/NCT00550173 | https://clinicaltrials.gov/study/NCT00383266
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT00079872 | Low Signal (COMPLETED) | stale_update_signal | Completed No Results Found Signal | None |
| NCT00550173 | Low Signal (COMPLETED) | stale_update_signal | Low Signal | large_enrollment_target_signal |
| NCT00383266 | Registry Stop Signal (TERMINATED) | stale_update_signal | Low Signal | rare_population_signal | strict_eligibility_signal |